Previous close | 10.35 |
Open | 10.35 |
Bid | 20.40 |
Ask | 24.10 |
Strike | 230.00 |
Expiry date | 2024-11-15 |
Day's range | 10.35 - 10.35 |
Contract range | N/A |
Volume | |
Open interest | 13 |
Charles River's (CRL) RMS arm sees lesser impact on demand than other life science sectors despite macroeconomic challenges in China.
On May 10, 2024, Joseph Laplume, Executive Vice President of Corporate Strategy & Development, sold 1,304 shares of Charles River Laboratories International Inc (NYSE:CRL).
Explore Charles River's (CRL) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.